5-Methoxytryptophan
Pharmaceutical compound
From Wikipedia, the free encyclopedia
5-Methoxytryptophan (5-MTP), or 5-methoxy-L-tryptophan, also known as 5-methoxy-α-carboxytryptamine or as cytoguardin, is an endogenous metabolite of tryptophan with anti-inflammatory and anti-fibrotic effects.[1][2][3] It is biosynthesized in two steps by tryptophan hydroxylase (TPH) and then by hydroxyindole O-methyltransferase (HIOMT), with 5-hydroxytryptophan (5-HTP) as a metabolic intermediate.[1][2][3] 5-MTP is also a metabolic precursor of 5-methoxytryptamine.[4] The compound promotes sleep in rodents similarly to melatonin.[5] In contrast to melatonin, 5-MTP did not show affinity for melatonin receptors.[6] It was first described in the scientific literature by at least 1951.[7]
- None
- 2504-22-5
25197-96-0
| Clinical data | |
|---|---|
| Other names | 5-MTP; 5-Methoxy-L-tryptophan; L-5-Methoxytryptophan; 5-MeO-tryptophan; α-Carboxy-5-methoxytryptamine; 5-Methoxy-α-carboxytryptamine; Cytoguardin |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H14N2O3 |
| Molar mass | 234.255 g·mol−1 |
| 3D model (JSmol) | |
| |
| |